Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review
Open Access
Abstract
Colorectal cancer (CRC) is currently the third most frequent form of malignancy and the second in terms of mortality. Inflammatory bowel diseases (IBDs) are recognized risk factors for this type of cancer. Despite a worldwide increase in the incidence of CRC, the risk of CRC-related death in IBD patients has declined over time, probably because of successful surveillance strategies, the use of more effective drugs in the management of remission and improved indications to colectomy. This notwithstanding, CRC 5-year survival in patients with IBD is poorer than in the general population. This review provides a summary of the epidemiological features, risk factors and various prevention strategies proposed for CRC in IBD patients. Moreover, there is a special focus on reporting and highlighting the various prevention strategies proposed by the most important international scientific societies, both in terms of chemoprevention and endoscopic surveillance. Indeed, in conducting the analysis, we have given attention to the current primary, secondary and tertiary prevention guidelines, attempting to emphasize unresolved research and clinical problems related to this topic in order to improve diagnostic strategies and management.Keywords
This publication has 137 references indexed in Scilit:
- Fusobacterium Is Associated with Colorectal AdenomasPLOS ONE, 2013
- Intestinal Inflammation Targets Cancer-Inducing Activity of the MicrobiotaScience, 2012
- Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term surveyJournal of Gastroenterology, 2012
- High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing CholangitisAmerican Journal of Gastroenterology, 2011
- Clinical Features, Treatment, and Survival of Patients With Colorectal Cancer With or Without Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2011
- Risk of colorectal cancer in self‐reported inflammatory bowel disease and modification of risk by statin and NSAID useCancer, 2010
- Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitisJournal of Clinical Investigation, 2008
- Surveillance of Dysplasia in Inflammatory Bowel Disease: The Gastroenterologist-Pathologist PartnershipClinical Gastroenterology and Hepatology, 2006
- Statins and cancer preventionNature Reviews Cancer, 2005
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003